Categories Uncategorized

4 Face Mask Myths

The Centers for Disease Control and Prevention (“CDC”) recently stated that “Cloth face coverings are one of the most powerful weapons we have to slow and stop the spread of the virus,” (https://ibn.fm/1yiUN). However, there are people that believe alternative sources, or unsubstantiated myths, such as those listed below.

  1. Wearing a mask causes carbon dioxide build-up, especially when worn for a long period of time

Some people claim they won’t be able to breathe if they have a mask on. However, there is no scientific truth behind this claim. Take for instance, health care workers, who wear masks for many hours over long periods of time during surgeries without any issues.

  1. Masks only protect other people, not the one wearing it

A mask protects both the individual wearing it as well as those around them. A recent study revealed that if a person has no mask on, their droplets can travel up to 8 feet. With a mask on, the droplets travel less than a foot.

Additionally, a mask keeps your nose and mouth covered. These are the two main ways that infected droplets enter an individual’s body.

  1. Masks with exhalation valves offer the same protection as regular masks and are also more comfortable

Masks that have exhalation valves actually put those around you at risk. This is because the valves expel droplets/germs into the air around you, making them unsafe as they offer minimal protection. They do not limit the spread of coronavirus.

  1. There is no need to observe social distancing guidelines while wearing a mask

These go hand in hand. Properly wearing a mask while practicing social distancing is the most effective way of limiting the spread of COVID-19. If you are in public and you need to remove your mask to eat or drink, you are advised to ensure you are 6 feet apart from other individuals.

Precision medicine companies like Predictive Oncology (NASDAQ: POAI) encourage individuals to follow CDC guidelines so that they don’t fall victim to these myths.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Study Finds That Errors in Brain Cell Division Could Trigger Cancer

Researchers at the University of Virginia have conducted a study that offers new insights into…

1 day ago

Regentis Biomaterials Ltd. (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair

Approximately 472,500 arthroscopic knee procedures in the U.S. each year involve cartilage damage, yet no…

1 day ago

Oncotelic Therapeutics Inc. (OTLC) Proving Small Biotech Can Out-Innovate Big Pharma with 28 Million Reasons Why

The global AI in drug-discovery market was valued at approximately $3.25 billion in 2026 and…

2 days ago

Scientists Inch Closer to Developing a Lung Cancer Blood Test

Unlike prostate, colon and breast cancers, the screening for lung cancer hasn’t been very successful. This is largely because screening focuses…

2 days ago

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio…

2 days ago

Health Care Affordability Crisis Creates Momentum for Single-Payer System in Massachusetts

As the cost of health care skyrockets across the U.S., residents in many states are…

4 days ago